Kinetics of hepatic transport of 4-methylumbelliferone in rats. Analysis by multiple indicator dilution method
- PMID: 3305862
- DOI: 10.1007/BF01062937
Kinetics of hepatic transport of 4-methylumbelliferone in rats. Analysis by multiple indicator dilution method
Abstract
Hepatic elimination of 4-methylumbelliferone (4-MU), which has been used as a model compound for conjugative metabolism, was studied by means of a multiple indicator dilution (MID) method in the isolated perfused rat liver. Using this method, three intrinsic hepatic clearances, CLint,inf, CLint,eff, and CLint,seq, which represent the influx, efflux, and sequestration processes, respectively, were obtained. When the dose was increased from a low dose (50 micrograms/rat liver) to a high dose (3000 micrograms/rat liver), the hepatic availability of 4-MU increased from 0.11 to 0.73. With increasing dose, the CLint,eff value increased approximately two times, while the CLint,seq value decreased to approximately one-third. The remarkable dose dependence of hepatic availability was due to nonlinearity in both CLint,eff and CLint,seq values. However, the CLint,inf value was almost independent of dose. The dose-dependent change in CLint,seq might be explained by the saturation of conjugative metabolism of 4-MU, while the increase in the CLint,eff value with increasing dose might be partly explained by the nonlinear tissue binding of 4-MU, since the tissue unbound fraction determined by an ultrafiltration method using liver homogenate increased approximately 1.5 times at higher concentration of 4-MU compared to that at lower concentrations. In addition, based on a comparison of the individual intrinsic clearances, i.e., CLint,inf, CLint,eff, and CLint,seq, the major determining process of the apparent hepatic intrinsic clearance of 4-MU is thought to be the sequestration process at the high dose. However, at the low dose, the membrane transport process (influx and efflux processes) as well as the sequestration process also determine the apparent hepatic intrinsic clearance.
Similar articles
-
Membrane-limited hepatic transport of the conjugative metabolites of 4-methylumbelliferone in rats.J Pharm Sci. 1988 Aug;77(8):688-92. doi: 10.1002/jps.2600770809. J Pharm Sci. 1988. PMID: 3210158
-
Pharmacokinetic study of 4-methylumbelliferone in rats: influence of dose on its first-pass hepatic elimination.J Pharmacobiodyn. 1986 Feb;9(2):117-24. doi: 10.1248/bpb1978.9.117. J Pharmacobiodyn. 1986. PMID: 3712212
-
Pharmacokinetic study of 4-methylumbelliferone in mice.J Pharmacobiodyn. 1987 May;10(5):195-200. doi: 10.1248/bpb1978.10.195. J Pharmacobiodyn. 1987. PMID: 3625453
-
Conjugative metabolism of 4-methylumbelliferone in the rat liver: verification of the sequestration process in multiple indicator dilution experiments.Chem Pharm Bull (Tokyo). 1987 Oct;35(10):4241-8. doi: 10.1248/cpb.35.4241. Chem Pharm Bull (Tokyo). 1987. PMID: 3325180 No abstract available.
-
Effect of albumin on hepatic uptake of warfarin in normal and analbuminemic mutant rats: analysis by multiple indicator dilution method.J Pharmacokinet Biopharm. 1986 Feb;14(1):51-64. doi: 10.1007/BF01059283. J Pharmacokinet Biopharm. 1986. PMID: 3746632
Cited by
-
Membrane transport in hepatic clearance of drugs. I: Extended hepatic clearance models incorporating concentration-dependent transport and elimination processes.Pharm Res. 1997 Jun;14(6):774-9. doi: 10.1023/a:1012106623696. Pharm Res. 1997. PMID: 9210196
-
Assessing Liver-to-Plasma Partition Coefficients and In Silico Calculation Methods: When Does the Hepatic Model Matter in PBPK?.Drug Metab Dispos. 2022 Oct 4;50(12):1501-12. doi: 10.1124/dmd.122.000994. Drug Metab Dispos. 2022. PMID: 36195337 Free PMC article.
-
Availability predictions by hepatic elimination models for Michaelis-Menten kinetics.J Pharmacokinet Biopharm. 1989 Dec;17(6):687-719. doi: 10.1007/BF01062125. J Pharmacokinet Biopharm. 1989. PMID: 2635740
-
Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes.Pharm Res. 1993 Apr;10(4):606-10. doi: 10.1023/a:1018918623658. Pharm Res. 1993. PMID: 8483847
-
Kinetic analysis of the dose-dependent hepatic handling of 1-anilino-8-naphthalene sulfonate in rats.J Pharmacokinet Biopharm. 1990 Aug;18(4):313-33. doi: 10.1007/BF01062271. J Pharmacokinet Biopharm. 1990. PMID: 2231322
References
MeSH terms
Substances
LinkOut - more resources
Research Materials